Zdrowie i gospodarka · 09/07/2007

FDA Releases Draft Guidance for Industry: Evidence-Based Review System for Scientific Evaluation of Health Claims

The Food and Drug Administration (FDA) has made available a draft guidance document outlining its new approach to reviewing scientific evidence for significant scientific agreement (SSA) and qualified health claims, aiming to provide a more evidence-based evaluation process.